Compare UCAR & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCAR | PAVM |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 9.3M |
| IPO Year | 2023 | 2016 |
| Metric | UCAR | PAVM |
|---|---|---|
| Price | $1.74 | $0.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $17.00 |
| AVG Volume (30 Days) | 22.4K | ★ 423.0K |
| Earning Date | 10-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,816,075.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 57.22 | N/A |
| 52 Week Low | $1.71 | $0.30 |
| 52 Week High | $9.43 | $0.90 |
| Indicator | UCAR | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 43.57 |
| Support Level | $1.71 | $0.32 |
| Resistance Level | $1.91 | $0.37 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 33.96 | 25.00 |
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.